Tsfg, LLC Orgenesis Inc. Transaction History

Tsfg, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 23, 2024	BUY	$0.44 - $0.96 $40 - $88	92 Added 9.2%	1,092 $1,000
Q2 2020 Jul 07, 2020	SELL	$3.6 - $7.84 $5,400 - $11,760	-1,500 Reduced 60.0%	1,000 $6,000
Q1 2019 Jan 27, 2020	BUY	$4.28 - $5.6 $10,700 - $14,000	2,500 New	2,500 $13,000

134K

Ticker ORGS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 25,545,800
Market Cap $28.1M
Description
Orgenesis Inc., a biotech company, focusing on cell and gene therapies worldwide. The company develops a Point of Care (POCare) platform that includes a pipeline of licensed POCare therapeutics that are processed and produced in closed automated POCare technology systems across a collaborative POCare network. It focuses on autologous therapies, ...

Get notified when there are updates to the investment portfolio of Tsfg, LLC, based on Form 13F filings with the SEC.

Stay updated on Tsfg, LLC with notifications on news.